Key result
Orthostatic test-identified sympathicotonia links to altered 24-hour electrodermal activity, unlike self-reported symptoms.
Why the study?
Post-COVID condition is often associated with sympathicotonia, but characterization using novel long-term electrodermal activity analysis via a smart ring and its clinical applicability had not been evaluated.
Does 14-day electrodermal activity (EDA) monitoring via a smart ring characterize sympathicotonia in post-COVID condition patients?
Observational (n=35)
Does 14-day electrodermal activity (EDA) monitoring via a smart ring characterize sympathicotonia in post-COVID condition patients?
Long-term EDA monitoring via a smart ring can objectively detect orthostatic test-identified sympathicotonia, particularly during late night, independently of self-reported symptoms.
Answers are grounded in this paper and cite their sources.
May support EDA over symptoms for objective sympathicotonia detection; leaves open clinical utility of smart ring monitoring in post-COVID.
PURPOSE: After SARS-CoV-2 infection, some patients develop post-COVID condition (PCC), often associated with sympathicotonia. This study aimed to characterize sympathicotonia in PCC patients using a novel long-term electrodermal activity (EDA) analysis via a smart ring and evaluate its clinical applicability. METHODS: Seventeen PCC patients were recruited from a Long Covid outpatient clinic, and 18 healthy controls volunteered. PCC patients were divided based on self-reported symptoms into those with or without sympathicotonia. A 14-day EDA monitoring was conducted. Sympathetic nervous system (SNS) activity was expressed as a double normalized index of electrodermal activity (DNE), with higher levels indicating higher SNS activity. Orthostatic tests were performed to identify orthostatic sympathicotonia. DNE levels, representing EDA, were compared to self-reported and orthostatic sympathicotonia. RESULTS: DNE levels did not differ between PCC patients with (N = 12) or without (N = 5) self-reported sympathicotonia or compared with nonsympathetic controls. When dividing all participants by orthostatic test results, DNE levels were lower during day (08:00-14:00; p < 0.05) but higher during late night (00:00-02:00; p < 0.05) in those with orthostatic sympathicotonia (N = 21) compared to those without (N = 14), with the 24-h comparison significant (p = 0.022). Among PCC patients, DNE levels were higher in orthostatic nonsympathicotonic (N = 7) than orthostatic sympathicotonic (N = 10) during morning (09:00-12:00; p < 0.05), with the 24-h comparison significant (p = 0.044). CONCLUSION: Self-reported symptoms did not distinguish sympathicotonia. However, individuals with orthostatic test-identified sympathicotonia had heightened EDA, indicating increased sympathetic activity, particularly during late night. PCC was not identifiable by EDA. Long-term EDA monitoring may provide an objective tool for detecting sympathicotonia independently of self-reported symptoms.
No takes yet. Share an insight, caveat, or question.
Mustonen et al. (2025) conducted an observational in Post-COVID condition (long covid) and sympathicotonia (n=35). Long-term electrodermal activity (EDA) monitoring via a smart ring vs. Healthy controls and participants without sympathicotonia was evaluated on Sympathetic nervous system activity expressed as a double normalized index of electrodermal activity (DNE) (p=0.022). Orthostatic test-identified sympathicotonia was associated with altered 24-hour electrodermal activity compared to those without, whereas self-reported symptoms did not distinguish it.
Synapse has enriched 10 related papers. Consider them for comparative context: